We are live on ! Find out more
MRTX

Mirati Therapeutics, Inc. Common Stock

Delisted

MRTX was delisted on the 22nd of January, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
ACA
1
Avoro Capital Advisors
New York
$388M
Vanguard Group
2
Vanguard Group
Pennsylvania
$330M +$13.3M +180,278 +4%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$242M +$41.7M +563,281 +19%
AH
4
Aviva Holdings
Bahamas
$219M
PA
5
Perceptive Advisors
New York
$194M -$6.07M -82,067 -3%
BlackRock
6
BlackRock
New York
$170M +$1.29M +17,385 +0.7%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$150M +$9.85M +133,158 +7%
BC
8
Boxer Capital
California
$140M
CCM
9
Camber Capital Management
Massachusetts
$140M +$99.9M +1,350,000 +208%
AC
10
Armistice Capital
New York
$133M -$11M -148,000 -7%
RI
11
RTW Investments
New York
$131M
State Street
12
State Street
Massachusetts
$110M -$22.6M -305,076 -16%
Ameriprise
13
Ameriprise
Minnesota
$103M +$581K +7,848 +0.5%
Franklin Resources
14
Franklin Resources
California
$102M +$128K +1,728 +0.1%
O
15
OrbiMed
New York
$99.1M +$24.3M +328,492 +30%
Adage Capital Partners
16
Adage Capital Partners
Massachusetts
$99.1M +$105M +1,418,747 New
BBA
17
Baker Bros. Advisors
New York
$98.5M
AG
18
Artal Group
Luxembourg
$92.5M +$16.6M +225,000 +20%
T. Rowe Price Associates
19
T. Rowe Price Associates
Maryland
$79.8M +$6.75M +91,225 +9%
EC
20
EcoR1 Capital
California
$70.9M +$75.1M +1,015,572 New
Morgan Stanley
21
Morgan Stanley
New York
$68.9M +$6.05M +81,721 +9%
RSCM
22
Rock Springs Capital Management
Maryland
$60.5M +$1.61M +21,799 +3%
PBA
23
Paradigm Biocapital Advisors
New York
$59.4M +$14.1M +190,417 +29%
Janus Henderson Group
24
Janus Henderson Group
$50.7M -$418K -5,649 -0.8%
CS
25
Candriam SCA
Luxembourg
$46.3M +$5.05M +68,217 +11%